Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road Shanghai, Shanghai, China.
Xuzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Xuzhou, 221000, China.
Lasers Med Sci. 2020 Jun;35(4):833-839. doi: 10.1007/s10103-019-02865-7. Epub 2019 Sep 5.
miR-548-3p is one of the members of miR-548 family, a large primate-specific miRNA gene family. The role of miR-548-3p in lung cancer was less studied. In this study, we found the expression of miR-548-3p was lower both in clinical tumor specimens and lung cancer cells compared with normal controls. In vitro, miR-548-3p inhibited lung cancer cell growth and promoted cell apoptosis at the S stage of cell cycle. The underlying mechanism of miR-548b-3p-induced cell proliferation inhibition and apoptosis may be associated with the inhibition of PI3K/AKT signaling pathway. In vivo, miR-548b-3p also suppressed tumor growth in xenografts model of lung cancer cells. Our results indicated that miR-548b-3p might be an anti-tumor target of lung cancer in the future.
miR-548-3p 是 miR-548 家族的成员之一,miR-548 家族是一个大型的灵长类特异性 miRNA 基因家族。miR-548-3p 在肺癌中的作用研究较少。在本研究中,我们发现 miR-548-3p 的表达在临床肿瘤标本和肺癌细胞中均低于正常对照。体外,miR-548-3p 抑制肺癌细胞生长并促进细胞周期 S 期的细胞凋亡。miR-548b-3p 诱导细胞增殖抑制和细胞凋亡的潜在机制可能与抑制 PI3K/AKT 信号通路有关。在体内,miR-548b-3p 也抑制了肺癌细胞异种移植模型中的肿瘤生长。我们的研究结果表明,miR-548b-3p 可能是未来肺癌的抗肿瘤靶点。